Pazopanib in Molecularly Selected Patients With Advanced NSCLC

NCT02193152 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped Terminated by sponsor

Conditions

Carcinoma, Non-Small Cell Lung
Non-Small Cell Lung Cancer
Nonsmall Cell Lung Cancer

Interventions

DRUG: Pazopanib

Sponsor

Washington University School of Medicine

Collaborators

[object Object]